Syndax Pharmaceuticals, Inc.SNDXNASDAQ
Loading
Year-over-year operating cash flow growth rate
Latest
-17.49%
↑ 91% vs avg
Percentile
P57
Within normal range
Streak
1 yr
Consecutive growthAccelerating
Average
-196.88%
Historical baseline
| Period | Value |
|---|---|
| 2025 | -17.49% |
| 2024 | -71.17% |
| 2023 | -20.14% |
| 2022 | -558.88% |
| 2021 | 140.88% |
| 2020 | -40.80% |
| 2019 | 26.15% |
| 2018 | -44.67% |
| 2017 | -34.74% |
| 2016 | -1347.98% |